Jeremy Grushcow

Biography

Jeremy is a partner in the Corporate group at Norton Rose OR LLP. His practice focuses on life science, cleantech and other technology-intensive transactions. He has represented pharmaceutical and biotech companies, private equity and VC firms and investment banks in connection with mergers and acquisitions, public and private offerings, licensing deals and other commercial agreements. Prior to joining Norton Rose, Mr. Grushcow practised at Kirkland & Ellis LLP in their Intellectual Property Transactions group and at Shearman & Sterling LLP in their Capital Markets group. Jeremy is the Corporate Secretary to the Board of the Ontario Biosciences Industry Organization (OBIO) and is a member of the Genetics Society of America and the American Association for the Advancement of Science. He is the founder of The Cross-Border Biotech Blog and has authored numerous publications in both legal and scientific journals including Counsel to Counsel, the Journal of Legal Studies and Genetics. Jeremy received a Ph.D. in Molecular Genetics and Cell Biology and a J.D. from the University of Chicago, where he was awarded the John M. Olin Prize, given to the outstanding student in Law and Economics. Jeremy is a partner in the Corporate group at Norton Rose OR LLP. His practice focuses on life science, cleantech and other technology-intensive transactions. He has represented pharmaceutical and biotech companies, private equity and VC firms and investment banks in connection with mergers and acquisitions, public and private offerings, licensing deals and other commercial agreements. Prior to joining Norton Rose, Mr. Grushcow practised at Kirkland & Ellis LLP in their Intellectual Property Transactions group and at Shearman & Sterling LLP in their Capital Markets group. Jeremy is the Corporate Secretary to the Board of the Ontario Biosciences Industry Organization (OBIO) and is a member of the Genetics Society of America and the American Association for the Advancement of Science. He is the founder of The Cross-Border Biotech Blog and has authored numerous publications in both legal and scientific journals including Counsel to Counsel, the Journal of Legal Studies and Genetics. Jeremy received a Ph.D. in Molecular Genetics and Cell Biology and a J.D. from the University of Chicago, where he was awarded the John M. Olin Prize, given to the outstanding student in Law and Economics.

Research Interest

Biochemistry